Atrial fibrillation in patients undergoing liver transplantation - A single-center experience

Transplantation Proceedings

Volumn 46, Issue 5, 2014, Pages 1432-1437

  Vannucci, A ^a   Rathor, R ^a   Vachharajani, N ^a   Chapman, W ^a   Kangrga, I ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COUMARIN; DIGOXIN; DILTIAZEM; DOBUTAMINE; ESMOLOL; FRESH FROZEN PLASMA; TRANEXAMIC ACID; TROPONIN I; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BRADYCARDIA; CAUSE OF DEATH; CHADS2 SCORE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CRYOPRECIPITATE; DIASTOLIC DYSFUNCTION; ERYTHROCYTE TRANSFUSION; EXERCISE TEST; EXTUBATION; FEMALE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEPATIC ARTERY THROMBOSIS; HEPATITIS C; HEPATOJEJUNOSTOMY; HOSPITAL READMISSION; HUMAN; IMPLANTED HEART PACEMAKER; INTENSIVE CARE UNIT; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER NECROSIS; LIVER TRANSPLANTATION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; MORTALITY; MULTIPLE ORGAN FAILURE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SURVIVAL TIME; THROMBOCYTE TRANSFUSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VENTRICULAR PACEMAKER; ATRIAL FIBRILLATION; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED;

ATRIAL FIBRILLATION; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84902455583     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.02.020     Document Type: Article

References (32)

1. Organ Procurement and Transplantation Network. Scientific Registry of Transplant Recipients annual data report 2012. Available at: http://optn.transplant.hrsa.gov/latestData/rptData.asp.
2. T.A. Aloia, R. Knight, A.O. Gaber, R.M. Ghobrial, and J.A. Goss Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors Liver Transpl 16 2010 950 959
3. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, and W.B. Borden et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 220
4. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, and K.A. Ellenbogen et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 e269 e367
5. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, and J.V. Selby et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
6. J.P. Piccini, B.G. Hammill, M.F. Sinner, P.N. Jensen, A.F. Hernandez, and S.R. Heckbert et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007 Circ Cardiovasc Qual Outcomes 5 2012 85 93
7. M.W. Rich Epidemiology of atrial fibrillation J Interv Card Electrophysiol 25 2009 3 8
8. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, and S. Ernst et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
9. Y. Miyasaka, M.E. Barnes, B.J. Gersh, S.S. Cha, K.R. Bailey, and W.P. Abhayaratna et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
10. W.B. Kannel, P.A. Wolf, E.J. Benjamin, and D. Levy Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 82 8A 1998 2N 9N
11. G.Y. Lip, C.M. Brechin, and D.A. Lane The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe Chest 142 6 2012 1489 1498
12. T.R. Fouad, W.M. Abdel-Razek, K.W. Burak, V.G. Bain, and S.S. Lee Prediction of cardiac complications after liver transplantation Transplantation 87 2009 763 770
13. T. Sakai, R.M. Planinsic, I.A. Hilmi, and J.W. Marsh Complications associated with percutaneous placement of venous return cannula for venovenous bypass in adult orthotopic liver transplantation Liver Transpl 13 2007 961 965
14. M. Chung, and I. Muntyan Atrial fibrillation during veno-venous bypass for orthotopic liver transplantation J Clin Anesth 23 2011 428 429
15. J.M. von Vital, A. Karachristos, A. Singhal, R. Thomas, and A. Jain Acute amiodarone hepatotoxicity after liver transplantation Transplantation 91 8 2011 e62 e64
16. C.J. Huang, C.L. Chen, C.S. Wang, K.W. Cheng, K.H. Chen, and C.C. Wang et al. Rhabdomyolysis after liver transplantation: a case report Transplant Proc 40 2008 2821 2822
17. J. Bargehr, J.F. Trejo-Gutierrez, B.G. Rosser, T. Patel, M.L. Yataco, and S. Pungpapong et al. Liver transplantation in patients with atrial fibrillation Transplant Proc 45 2013 2302 2306
18. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
19. J.H. Indik, and J.S. Alpert The patient with atrial fibrillation Am J Med 122 2009 415 418
20. A. Saxena, D. Dinh, J. Dimitriou, C. Reid, J. Smith, and G. Shardey et al. Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery Interact Cardiovasc Thorac Surg 16 2013 488 494
21. M.A. Rosenberg, and W.J. Manning Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal Circulation 126 2012 2353 2362
22. J. Kosiuk, O. Breithardt, K. Bode, J. Kornej, A. Arya, and T. Gaspar et al. Left ventricular diastolic dysfunction and thromboembolic risk in atrial fibrillation: diastolic dysfunction and thromboembolic risk in AF Int J Cardiol 2013
23. T.F. Dowsley, D.B. Bayne, A.N. Langnas, I. Dumitru, J.R. Windle, and T.R. Porter et al. Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation Transplantation 94 2012 646 651
24. M. Zamirian, T. Sarmadi, K. Aghasadeghi, and M.B. Kazemi Liver cirrhosis prevents atrial fibrillation: A reality or just an illusion? J Cardiovasc Dis Res 3 2012 109 112
25. M. Levy, D. Heels-Ansdell, R. Hiralal, M. Bhandari, G. Guyatt, and S. Yusuf et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis Anesthesiology 114 2011 796 806
26. M.B. Rosenman, T.A. Simon, E. Teal, P. McGuire, D. Nisi, and J.D. Jackson Perceived or actual barriers to warfarin use in atrial fibrillation based on electronic medical records Am J Ther 19 2012 330 337
27. A. di Micoli, A. Zambruni, E. Bracci, B. Benazzi, P. Zappoli, and A. Berzigotti et al. "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval Dig Liver Dis 41 2009 535 538
28. P. Zimetbaum Amiodarone for atrial fibrillation N Engl J Med 356 2007 935 941
29. M. Bernardi, C. Maggioli, V. Dibra, and G. Zaccherini QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? Expert Rev Gastroenterol Hepatol 6 2012 57 66
30. L.S. Wann, A.B. Curtis, C.T. January, K.A. Ellenbogen, J.E. Lowe, and N.A. Estes 3rd et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 223 242
31. R. de Caterina, S. Husted, L. Wallentin, F. Andreotti, H. Arnesen, and F. Bachmann et al. New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper J Am Coll Cardiol 59 2012 1413 1425
32. A. Tripodi, and P.M. Mannucci The coagulopathy of chronic liver disease N Engl J Med 365 2011 147 156